Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,297
Sort by:
2021 Biotechnology Research Review
US$ 1,500.00
... and accelerated development and growth of markets in biotechnology, in the period of review. Notable recent advancements in biotechnology are CRISPR, Spheroids for drug development, Quantitative ...
February 2022
312 pages
Biotechnology & Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Services (Consulting, Auditing And Assessment, Regulatory Affairs), By End Use (Pharma, Biotech), By Region, And Segment Forecasts, 2022 - 2030
US$ 5,950.00
... 50.0 billion was spent on pharmaceutical R&D activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth over the ...
February 2022
133 pages
Membrane Bioreactors: Global Markets
US$ 2,750.00
... membrane component of MBRs, the biological component, system configurations, typical MBR performance, cost analyses, system applications, companies active in the market, market ... overview of the global membrane bioreactors markets used for wastewater treatment Analyses of global market trends, with data from ...
February 2022
178 pages
Live Biotherapeutic Products and Microbiome Manufacturing Market by Type of Product Manufactured (API and FDF), Type of Formulation (Solids, Oral Liquids and Injectables), Type of Primary Packaging Used (Blister Packs, Glass / Plastic Bottles, Pouches / Sachets and Vials), Scale of Operation (Clinical and Commercial), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022 – 2035
US$ 4,799.00
The projected value of microbiome manufacturing market is expected to be valued at USD 23 million in 2022 and is anticipated to grow at a CAGR of 20% during the forecast period 2022-2035. In light of...
February 2022
305 pages
Global In Situ Hybridization Market Size study, By Technology (Fluorescent In Situ Hybridization, Chromogenic In Situ Hybridization), By Probe Type (DNA, RNA), By Product (Instruments, Kits & Probes, Software, Services) By Application, (Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Others) By End-use (Hospitals & Diagnostic Laboratories, CROs, Academic& Research Institutes, Others) and Regional Forecasts 2021-2027
US$ 4,950.00
Global In Situ Hybridization (ISH) Market to reach USD 1.91 billion by 2025. Global In Situ Hybridization (ISH) Market valued approximately USD 970.80 million in 2016 ... in circulating tumor cells (CTCs). The regional analysis of Global In Situ Hybridization (ISH) Market is considered for the key regions such as ...
January 2022
200 pages
Asia Pacific Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer, Autoimmune Disease, Blood Disorder, Diabetes), Manufacturing (Contract, Inhouse), End User (Hospitals and Clinics, Research Institutes), and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
Asia Pacific biosimilars market will grow by 30.7% annually with a total addressable market cap of $140.4 billion over 2021-2030 owing to the affordability of biosimilar-based treatment, rising incide...
November 2021
116 pages
Europe Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer, Autoimmune Disease, Blood Disorder, Diabetes), Manufacturing (Contract, Inhouse), End User (Hospitals and Clinics, Research Institutes), and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
Europe biosimilars market was valued at $5,847.6 million in 2020 and will grow by 23.1% annually over 2020-2030 owing to the affordability of biosimilar-based treatment, rising incidence of chronic di...
November 2021
121 pages
Global Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer, Autoimmune Disease, Blood Disorder, Diabetes), Manufacturing (Contract, Inhouse), End User (Hospitals and Clinics, Research Institutes), and Region: Trend Forecast and Growth Opportunity
US$ 2,720.00
Global biosimilars market will reach $113.25 billion by 2030, growing by 25.7% annually over 2020-2030 driven by the affordability of biosimilar-based treatment, rising incidence of chronic diseases d...
November 2021
180 pages
North America Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer, Autoimmune Disease, Blood Disorder, Diabetes), Manufacturing (Contract, Inhouse), End User (Hospitals and Clinics, Research Institutes), and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
North America biosimilars market is expected to grow by 25.1% annually in the forecast period and reach $27.57 billion by 2030 driven by the affordability of biosimilar-based treatment, rising inciden...
November 2021
116 pages
Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Impact of COVID-19, Initiatives, Funding, Major Deals, 35 Company Profiles and Recent Developments - Forecast to 2028
US$ 3,290.00
The global liquid biopsy market is predicted to reach US$ 9.53 Billion by 2028. Liquid biopsy tests are executed to understand the molecular aspects of cancer across the healthcare and research settin...
October 2021
552 pages
Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker (Exosomes, CTC), By Technology (NGS, PCR Microarrays), By Sample Type, By Region (APAC, North America), And Segment Forecasts, 2021 - 2028
US$ 5,950.00
The global liquid biopsy market size is expected to reach USD 5.96 billion by 2030, according to a new report by Grand ... period. Enhanced view of tumor provided by liquid biopsy technology is estimated to augment the market in coming years. While tissue biopsies have been standard for cancer ...
October 2021
180 pages
Global Markets for Media, Sera and Reagents in Biotechnology
US$ 2,750.00
... 32 additional tables Detailed overview and industry analysis of the global markets for media, sera and reagents used in cell culture within the biotechnology industry Country specific data and analysis for ...
September 2021
195 pages
Bioprocess Containers Market by Type(2D and 3D Bags, Accessories), Application(Process development, Upstream and Downstream Process), End User(Pharma & Biopharma Companies, CMOs & CROs, Academic & Research Institute), & Region – Global Forecast to 2026
US$ 4,950.00
... Fluids Control (Argentina). Research Coverage: The report analyzes the bioprocess containers market by type, application, end user, and region. Apart from comprehensive geographic ...
September 2021
207 pages
Global Biotechnology Market, By Application (Bio-Pharmaceuticals, Bio-IT, Bio- Industrial, Bio-Agriculture), By End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, Others), By Region, Competition Forecast & Opportunities, 2026
US$ 4,900.00
Global biotechnology market stood at USD627.63 billion in 2020 and is expected to grow at a CAGR of 8.57% during the forecast period. The growth can be ascribed to the growing demand for biotechnology...
August 2021
111 pages
Biospecimen Procurement Market by Therapeutic Area (Oncological Disorders and Other Disorders), Type of Biospecimen for Oncological Studies (FFPE Tissue, Frozen Tissue, Plasma / Serum and Other Biospecimens), Type of Biospecimen for Non-Oncological Studies (Blood Products, Human Tissue and Other Biospecimens), Key Geographical Regions (North America (US and Canada), Europe (Germany, France, Italy, UK, Spain and Other European Countries) and Asia Pacific (China, India, Japan and other Asia-Countries and Rest of the World)): Industry Trends and Global Forecasts, 2021-2030
US$ 4,799.00
The biospecimen procurement market is expected to reach USD 52 million in 2021 and anticipated to grow at a CAGR of 16% during the forecast period 2021-2035. Biomedical research follows a cyclical pat...
August 2021
159 pages
Nanobiotechnology: Applications and Global Markets
US$ 2,750.00
Report : The scope of this investigation includes the major viable nanobiotechnologies that are currently being implemented in various industries. The study scope includes the major nanotechnology for...
July 2021
126 pages
